Mavridis, T.; Deligianni, C.I.; Karagiorgis, G.; Daponte, A.; Breza, M.; Mitsikostas, D.D.
Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence—What Do We Know So Far? Pharmaceuticals 2021, 14, 700.
https://doi.org/10.3390/ph14070700
AMA Style
Mavridis T, Deligianni CI, Karagiorgis G, Daponte A, Breza M, Mitsikostas DD.
Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence—What Do We Know So Far? Pharmaceuticals. 2021; 14(7):700.
https://doi.org/10.3390/ph14070700
Chicago/Turabian Style
Mavridis, Theodoros, Christina I. Deligianni, Georgios Karagiorgis, Ariadne Daponte, Marianthi Breza, and Dimos D. Mitsikostas.
2021. "Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence—What Do We Know So Far?" Pharmaceuticals 14, no. 7: 700.
https://doi.org/10.3390/ph14070700
APA Style
Mavridis, T., Deligianni, C. I., Karagiorgis, G., Daponte, A., Breza, M., & Mitsikostas, D. D.
(2021). Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence—What Do We Know So Far? Pharmaceuticals, 14(7), 700.
https://doi.org/10.3390/ph14070700